Personal Observation: Intravenous Aminophylline Treatment for Migraine

Migraine is common condition, often affecting young patients and causing disruption in the home and workplace alike. The impact of patients presenting to emergency room services with intractable headache is significant, often tying up space and resources in the tedious wait for a narcotic and sedative “cure.” In Canada alone, 3.2 million adults suffer from migraines, and the condition costs the Canadian economy an estimated $500 million annually. Absenteeism and loss of productivity resulting from migraines cost $20 every second.